![Jan Vos van Marken](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Jan Vos van Marken is currently the Managing Director at Utrecht Holdings since 2014.
Prior to this, he worked as an Investment Manager at HealthByte BV.
Postes actifs de Jan Vos van Marken
| Sociétés | Poste | Début |
|---|---|---|
Utrecht Holdings
 Utrecht Holdings Investment ManagersFinance Utrecht Holdings invests in companies located in Netherlands primarily in Utrecht region. The firm targets companies operating in the fields of biotech, medtech and education sectors. It provides financing for pre-seed, seed and early stage capital requirements. | Private Equity Investor | 01/07/2014 |
Anciens postes connus de Jan Vos van Marken
| Sociétés | Poste | Fin |
|---|---|---|
HealthByte BV /Management/
 HealthByte BV /Management/ Investment ManagersFinance HaealthByte BV is an active manager that provides equity financing for early-stage capital requirements. The firm targets companies operating in the health technology. It invests in young corporations located in Netherlands. | Private Equity Investor | 23/08/2018 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
3
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Utrecht Holdings
Utrecht Holdings Investment ManagersFinance Utrecht Holdings invests in companies located in Netherlands primarily in Utrecht region. The firm targets companies operating in the fields of biotech, medtech and education sectors. It provides financing for pre-seed, seed and early stage capital requirements. | Finance |
HealthByte BV /Management/
HealthByte BV /Management/ Investment ManagersFinance HaealthByte BV is an active manager that provides equity financing for early-stage capital requirements. The firm targets companies operating in the health technology. It invests in young corporations located in Netherlands. | Finance |
